ARCT News - Candlesense

Arcutis to Present at Upcoming Investor Conferences

Arcutis today announced that management will participate in three upcoming investor conferences.

6 days ago

Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the devel...

Are there any partnership or licensing updates that could materially impact future cash flows? What competitive threats exist for Arcturus' liver and respiratory rare disease therapeutics? How might the recent financial update affect the stock's short‑term technical momentum?

Earnings

14 days ago

Arcutis Announces Second Quarter 2025 Financial Results and Provides Business Update

Arcutis today reported financial results for the quarter ended June 30, 2025, and provided a business update.

What risks or opportunities did management highlight in the business update, and how might they affect the stock's risk/reward profile? Are there any notable changes in guidance for R&D spending and the timeline for upcoming product launches? How does Arctis' valuation (P/E, EV/EBITDA, price-to-sales) compare with peers in the dermatology/ biotech sector after this release?

Earnings

19 days ago